SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-181969
Filing Date
2015-05-11
Accepted
2015-05-11 16:16:07
Documents
4
Period of Report
2015-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d923770d8k.htm 8-K 13937
2 EXHIBIT 99.1 d923770dex991.htm EX-99.1 33468
3 GRAPHIC g923770ex99_1pg01.jpg GRAPHIC 14406
4 GRAPHIC g923770ex99_1pg02logo.jpg GRAPHIC 12010
  Complete submission text file 0001193125-15-181969.txt   85210
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 15850929
SIC: 2834 Pharmaceutical Preparations